diaTribe’s annual Lightning Talks event elevates leaders and advocates in the diabetes community to share their insights on diabetes stigma.
Tackling diabetes stigma and its devastating effects will rely on courageous advocates and creative solutions. Right now the status quo is bogged down by harmful cultural narratives, misconceptions about diabetes, and not nearly enough collaboration. We think it’s time for a bit of disruption and we want to challenge everyone to join us in finding inspired, creative, radical, and out-of-the-box solutions. Watch the diaTribe Foundation’s d22 Lightning Talks, featuring four incredible speakers:
Thank you so much to our program sponsors, Dexcom and Eli Lilly & Co., that helped make this event possible.
As we continue our quest to dismantle the toxicity of diabetes stigma we invite you to hear several amazing speakers share the stories they weave to create changes in the hearts and minds of their audiences. The idea began with a TED Talk by Nigerian author Chimamanda Ngozi Adichie on the danger of a single story. Her talk about the importance of sharing stories, and even more importantly, sharing many different stories is incredibly inspiring. Watch the diaTribe Foundation’s d21 Lightning Talks, featuring three dynamic speakers:
Thank you so much to our program sponsors, One Drop, Abbott, AstraZeneca, Dexcom, and Sanofi, that helped make this event possible.
To address diabetes stigma, first we have to understand it. From hearing personal stories that detail experiences of stigma, to learning about its impacts and successful strategies to address it from other stigmatized conditions and identities, to getting a crash course in the power of narrative framing, this year’s Lightning Talks will help us drill exactly what diabetes stigma is so we can begin crafting interventions that will reduce the burden of stigma for people with diabetes. Watch the diaTribe Foundation’s d20 Lightning Talks, featuring five amazing speakers:
Thank you so much to our program sponsors, Abbott, Sanofi, Boehringer Ingelheim/Lilly, AstraZeneca, Merck/Pfizer, and Novo Nordisk, that helped make this event possible.